tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Aprea Therapeutics Inc (APRE)
NASDAQ:APRE
US Market
APRE
Aprea Therapeutics
RESEARCH TOOLSreports

Aprea Therapeutics (APRE) Stock News & Sentiment

Compare
486 Followers
Advancing APR-1051 in HPV-Positive Cancers and Extended Cash Runway Underpin Aprea Therapeutics Buy Rating and $5 Target
Premium
Ratings
Advancing APR-1051 in HPV-Positive Cancers and Extended Cash Runway Underpin Aprea Therapeutics Buy Rating and $5 Target
5d ago
APRE
Aprea Therapeutics Secures $3.1M in Private Placement
Premium
Company Announcements
Aprea Therapeutics Secures $3.1M in Private Placement
14d ago
8K
APRE
Aprea Therapeutics: Promising Advancements in Synthetic Lethality Programs Drive Buy Rating
Premium
Ratings
Aprea Therapeutics: Promising Advancements in Synthetic Lethality Programs Drive Buy Rating
1M ago
APRE
Aprea Therapeutics Reports Ongoing Financial Challenges
Premium
Company Announcements
Aprea Therapeutics Reports Ongoing Financial Challenges
1M ago
APRE
Aprea Therapeutics Reports Q3 Results and Clinical Updates
Premium
Company Announcements
Aprea Therapeutics Reports Q3 Results and Clinical Updates
1M ago
8K
APRE
Aprea Therapeutics Advances ATRN-119 Study for Solid Tumors
Premium
Company Announcements
Aprea Therapeutics Advances ATRN-119 Study for Solid Tumors
2M ago
APRE
Aprea Therapeutics Advances with Phase 1 Study of APR-1051 in Solid Tumors
Premium
Company Announcements
Aprea Therapeutics Advances with Phase 1 Study of APR-1051 in Solid Tumors
2M ago
APRE
More APRE News >

APRE News on the Web

Maxim Group Reaffirms Their Buy Rating on Aprea Therapeutics (APRE)
TipRanks News
Neutral
Aprea Therapeutics Reports Promising Trial Results for APR-1051
TipRanks News
Neutral
Sutro Biopharma, Inc. (STRO) Reports Q4 Loss, Tops Revenue Estimates
Zacks
Neutral
Aprea Therapeutics Announces Agreement with MD Anderson Cancer Center to Explore APR-1051 as a Potential Treatment for Head and Neck Squamous Cell Carcinoma
Yahoo Finance
Neutral
Merus N.V. (MRUS) Reports Q4 Loss, Lags Revenue Estimates
Zacks
Neutral
Aprea Therapeutics provides update on existing patent portfolio
Yahoo Finance
Neutral
Aprea Therapeutics Announces Strategic IP Portfolio Evolution in DNA Damage Response Cancer Therapeutics
Yahoo Finance
Neutral
Aprea Therapeutics’ Promising ATRN-119: A Buy Rating Amid Optimized Dosing and Safety Advancements
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
APRE
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average56%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is APRE’s Media Buzz Sentiment?
1 articles about APRE were published this week. In an average week, 1 articles are published.
    What is APRE’s weekly average amount of articles?
    In an average week, 1 articles about APRE are published.
      What is APRE’s News Sentiment?
      50% of articles about APRE were positive this week, compared to its sector average of 56%.
        Healthcare Stocks that are Trending in the News
        CYTKCytokinetics
        PCSAProcessa Pharmaceuticals
        ATAIATAI Life Sciences
        JNJJohnson & Johnson
        ANIPANI Pharmaceuticals
        Showing the stocks with the most bullish news sentiment over the past week